Presentation is loading. Please wait.

Presentation is loading. Please wait.

Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review  Thomas S. Huber, MD, PhD,

Similar presentations


Presentation on theme: "Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review  Thomas S. Huber, MD, PhD,"— Presentation transcript:

1 Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review  Thomas S. Huber, MD, PhD, Jeffrey W. Carter, BS, Randy L. Carter, PhD, James M. Seeger, MD  Journal of Vascular Surgery  Volume 38, Issue 5, Pages (November 2003) DOI: /S (03)

2 Figure Patency rate (percent patent) for autogenous (Auto) and polytetrafluoroethylene (PTFE) upper extremity arteriovenous hemodialysis accesses plotted against time (months), with positive standard error bars. Both primary (Auto 1, PTFE 1) and secondary (Auto 2, PTFE 2) patency rates for the two access types are shown. Patency rates for autogenous accesses are better than for their corresponding PTFE counterparts, with the one exception of the initial (1.5 months) time point for primary patency comparison. Journal of Vascular Surgery  , DOI: ( /S (03) )


Download ppt "Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review  Thomas S. Huber, MD, PhD,"

Similar presentations


Ads by Google